Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130097) titled 'A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Pfizer
Condition:
Healthy Participant
Intervention:
Drug: PF-07220060
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: August 14, 2025
Target Sample Size: 34
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130097
Published by HT Digital Content Services with permission fro...